HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 204 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,627,778 | +120.5% | 42,612 | +108.2% | 0.00% | +200.0% |
| Q2 2023 | $738,280 | -26.4% | 20,468 | -9.2% | 0.00% | -50.0% |
| Q1 2023 | $1,002,579 | -20.6% | 22,540 | +1.5% | 0.00% | 0.0% |
| Q4 2022 | $1,263,407 | -28.8% | 22,204 | -50.5% | 0.00% | -33.3% |
| Q3 2022 | $1,775,000 | -87.2% | 44,876 | -85.8% | 0.00% | -86.4% |
| Q2 2022 | $13,876,000 | +307.9% | 315,229 | +269.6% | 0.02% | +340.0% |
| Q1 2022 | $3,402,000 | -23.3% | 85,295 | -22.7% | 0.01% | -16.7% |
| Q4 2021 | $4,435,000 | -2.1% | 110,284 | -0.8% | 0.01% | 0.0% |
| Q3 2021 | $4,530,000 | +25.3% | 111,224 | +39.7% | 0.01% | +20.0% |
| Q2 2021 | $3,616,000 | +120.8% | 79,617 | +102.7% | 0.01% | +150.0% |
| Q1 2021 | $1,638,000 | -86.4% | 39,286 | -86.0% | 0.00% | -90.0% |
| Q4 2020 | $12,010,000 | +181.3% | 281,244 | +73.1% | 0.02% | +150.0% |
| Q3 2020 | $4,269,000 | -53.7% | 162,473 | -52.8% | 0.01% | -55.6% |
| Q2 2020 | $9,226,000 | +15.5% | 344,145 | -22.5% | 0.02% | 0.0% |
| Q1 2020 | $7,987,000 | +28.2% | 443,965 | +26.3% | 0.02% | +100.0% |
| Q4 2019 | $6,232,000 | +1423.7% | 351,523 | +1233.1% | 0.01% | +800.0% |
| Q3 2019 | $409,000 | +42.5% | 26,368 | +57.7% | 0.00% | – |
| Q2 2019 | $287,000 | +37.3% | 16,716 | +28.9% | 0.00% | – |
| Q1 2019 | $209,000 | +11.8% | 12,966 | +1.2% | 0.00% | – |
| Q4 2018 | $187,000 | -96.9% | 12,806 | -96.2% | 0.00% | -100.0% |
| Q3 2018 | $6,048,000 | -67.2% | 332,882 | -69.5% | 0.01% | -67.9% |
| Q2 2018 | $18,441,000 | -32.5% | 1,093,130 | -21.7% | 0.03% | -33.3% |
| Q1 2018 | $27,332,000 | +48.4% | 1,395,190 | +53.4% | 0.04% | +68.0% |
| Q4 2017 | $18,422,000 | +8273.6% | 909,286 | +7073.3% | 0.02% | – |
| Q3 2017 | $220,000 | +46.7% | 12,676 | +8.1% | 0.00% | – |
| Q2 2017 | $150,000 | +7.1% | 11,726 | +8.7% | 0.00% | – |
| Q1 2017 | $140,000 | +30.8% | 10,786 | 0.0% | 0.00% | – |
| Q4 2016 | $107,000 | -25.7% | 10,786 | -9.3% | 0.00% | – |
| Q3 2016 | $144,000 | +50.0% | 11,886 | +6.4% | 0.00% | – |
| Q2 2016 | $96,000 | -90.1% | 11,166 | -89.1% | 0.00% | -100.0% |
| Q1 2016 | $969,000 | -91.6% | 102,366 | -84.5% | 0.00% | -90.5% |
| Q4 2015 | $11,475,000 | +79.1% | 662,166 | +38.8% | 0.02% | +61.5% |
| Q3 2015 | $6,407,000 | +99.8% | 477,066 | +236.0% | 0.01% | +116.7% |
| Q2 2015 | $3,206,000 | +632.0% | 141,966 | +362.9% | 0.01% | +500.0% |
| Q1 2015 | $438,000 | +305.6% | 30,666 | +174.6% | 0.00% | – |
| Q4 2014 | $108,000 | -5.3% | 11,166 | -11.1% | 0.00% | – |
| Q3 2014 | $114,000 | -53.3% | 12,566 | -49.1% | 0.00% | – |
| Q2 2014 | $244,000 | +58.4% | 24,689 | +103.6% | 0.00% | – |
| Q1 2014 | $154,000 | -13.0% | 12,126 | +2.5% | 0.00% | – |
| Q4 2013 | $177,000 | +9.9% | 11,826 | -19.1% | 0.00% | – |
| Q3 2013 | $161,000 | +41.2% | 14,626 | +2.1% | 0.00% | – |
| Q2 2013 | $114,000 | – | 14,326 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |